GSK pledges $30bn US investment as UK's pharma woes deepen

The company is the latest pharma firm to have either reduced spending in the UK or diverted it to the US.

Več na: https://www.bbc.com/news/articles/c4g58x3441ko?at_medium=RSS&at_campaign=rss

nazaj